Laser-assisted selection of immotile spermatozoa has no effect on obstetric and neonatal outcomes of TESA-ICSI pregnancies

• Published in: Reproductive biology and endocrinology 2021-10, Vol.19 (1), p.159-159, Article 159
• Main Authors: Chen, Huanhua, Wang, Caizhu, Zhou, Hong, Shu, Jinhui, Gan, Xianyou, Xu, Kongrong, Wu, Zhulian, Deng, Xihe, Huang, Guiting, Lin, Ruoyun
• Format: Article
• Language: English
• Subjects: Adult; Azoospermia - epidemiology; Azoospermia - pathology; Azoospermia - therapy; Birth weight; Care and treatment; Case-Control Studies; Cell Separation - methods; China - epidemiology; Comparative analysis; Embryos; Endometrium; Female; Fertilization in Vitro - methods; Gestational age; Humans; Immotile spermatozoa; Implantation; Infant, Newborn; Infants (Newborn); Intracytoplasmic spermatozoa injection; Laser; Lasers; Male; Morphology; Motility; Neonates; Newborn babies; Obstetric outcome; Obstetrics; Oocytes; Ovaries; Ovulation; Pregnancy; Pregnancy Outcome - epidemiology; Pregnancy Rate; Pregnant women; Premature birth; Retrospective Studies; Sperm; Sperm Injections, Intracytoplasmic - methods; Sperm Motility; Sperm Retrieval; Spermatozoa; Testes; Testicular sperm aspiration; Vagina
• ISSN: 1477-7827; 1477-7827
• DOI: 10.1186/s12958-021-00835-9

Azoospermic patients have benefited from both epididymal and testicular spermatozoa intracytoplasmic sperm injection (ICSI) treatment and lasers have been used to identify viable, immotile spermatozoa before the procedure. There are limited studies on the safety of laser-assisted selection of immotile spermatozoa. The aim of this study was to investigate the impact of laser-assisted selection of immotile spermatozoa on the obstetric and neonatal outcomes after ICSI. A retrospective comparative study was conducted on outcomes of ICSI cycles with testicular spermatozoa from June 2014 to June 2018. Of 132 cycles, 33 were allocated to the test group and oocytes were injected with immotile spermatozoa selected by laser, 99 cycles were allocated as control group. Compared with the control group, no significant differences were found in the pregnancy, implantation, miscarriage and live birth rates in the test group in either fresh or frozen transfer cycles. The cumulative live birth rate in the test group was 69.70%, which was slightly higher than in the control group (60.61%), but this was not statistically different. There were no differences in the average gestational age, premature birth rate, neonatal birth weight, and the malformation rate between the test and control groups (P > 0.05). In addition, the obstetric outcome between the two groups were not different (P > 0.05). No negative effect on perinatal and neonatal outcomes was seen by using laser-assisted selection of immotile spermatozoa for TESA-ICSI. This study endorses the use of laser-assisted selection of viable spermatozoa for ICSI cycles.